Risk for Heart Failure Increased for Women Taking β-Blockers
Difference of 4.6 percent found between women and men in rate of heart failure at presentation for ACS
COVID-19-Related Symptoms Persist After Recovery
Only 12.6 percent of patients completely free of any COVID-19-related symptoms
Patterns Changing for Heart Disorder Hospitalizations in Canada
Rates up for acquired valvular heart disease, vascular cognitive impairment, and congenital heart disease
Incidence of Takotsubo Cardiomyopathy Up During COVID-19
Incidence proportion 7.8 percent during March, April 2020 versus 1.5 to 1.8 percent before pandemic
Half of Individuals With MI at Age 50 or Younger Are Smokers
Smoking cessation linked to reduced risk for all-cause and cardiovascular mortality in this population
Electronic Health Records Fail to Detect Many Medication Errors
Though broadly used in U.S. hospitals, EHRs fail to detect up to one-third of medication errors
Statin Use May Cut All-Cause, CVD Mortality in Those 75 and Older
Reductions in risk seen for all-cause, CV mortality and composite of atherosclerotic CV events
Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
Highest rates of adverse events seen within first month after initiating short course of oral steroids
Excessive Sugar Tied to Fat Deposits Around Heart, Other Organs
These higher-risk fat deposits linked to greater risk for heart disease and diabetes
Acute Ischemic Stroke Risk Higher With COVID-19 Than Influenza
Higher risk remains even when adjusting for demographic and clinical features
